Akebia Therapeutics, Inc. Contracts & Agreements

165 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Underwriting Agreement, dated March 19, 2025, by and among the Company, Leerink Partners LLC and Piper Sandler & Co
Underwriting Agreements
Akebia Therapeutics, Inc.
Biotechnology
2025
Fourth Amended and Restated Non-Employee Director Compensation Program, effective January 27, 2025
Compensation Agreements
Akebia Therapeutics, Inc.
Biotechnology
2025
Product Agreement, dated August 29, 2017, by and between Keryx Biopharmaceuticals, Inc. and Patheon Inc. (an affiliate of Patheon Manufacturing Services LLC) related to the Master...
Services Agreements
Akebia Therapeutics, Inc.
Biotechnology
2025
Second Amendment to Agreement for the Provision of a Loan Facility, dated February
Loan Agreements
Akebia Therapeutics, Inc.
Biotechnology
2025
Amendment #1 to License Agreement, dated August 30, 2024, by and among Akebia Therapeutics, Inc., Keryx Biopharmaceuticals, Inc. and Averoa SAS
License Agreements
Akebia Therapeutics, Inc.
Biotechnology
2024
Amendment #1 to Supply Agreement, dated October 15, 2024, by and between the Company and STA Pharmaceutical Hong Kong Limited
Supply Agreements
Akebia Therapeutics, Inc.
Biotechnology
2024
Seventh Amend
Akebia Therapeutics, Inc.
Biotechnology
MA
2024
Amendment #2 to Supply Agreement, dated as of April 15, 2024, by and between the Company and STA Pharmaceutical Hong Kong Limited
Supply Agreements
Akebia Therapeutics, Inc.
Biotechnology
2024
Amendment #1 to Second Amended and Restated License Agreement, dated May 3, 2024, by and between the Company and Vifor (International) Ltd
License Agreements
Akebia Therapeutics, Inc.
Biotechnology
2024
Termination and Settlement Agreement, dated July 10, 2024, by and between the Company and Vifor (International) Ltd
Termination Agreements
Akebia Therapeutics, Inc.
Biotechnology
NY
2024
Amendment #1 t
Akebia Therapeutics, Inc.
Biotechnology
NY
2024
Separation Agreement
Separation Agreements
Akebia Therapeutics, Inc.
Biotechnology
2024
Form of Warrant
Warrant Agreements
Akebia Therapeutics, Inc.
Biotechnology
2024
Third Amended and Restated Non-Employee Director Compensation Program, effective January 1, 2024
Compensation Agreements
Akebia Therapeutics, Inc.
Biotechnology
2024
Form of Officer Executive Severance Agreement (Reflecting Clawback Policy)
Severance Agreements
Akebia Therapeutics, Inc.
Biotechnology
MA
2024
Form of Officer Cash Bonus Agreement (Reflecting Clawback Policy)
Bonus & Incentive Agreements
Akebia Therapeutics, Inc.
Biotechnology
2024
Form of Officer Stock Option Agreement under 2023 Stock Incentive Plan (Reflecting Clawback Policy)
Bonus & Incentive Agreements
Akebia Therapeutics, Inc.
Biotechnology
2024
Form of Officer Restricted Stock Unit Agreement under 2023 Stock Incentive Plan (Reflecting Clawback Policy)
Bonus & Incentive Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2024
Form of Officer Inducement Award Stock Option
Stock Agreements
Akebia Therapeutics, Inc.
Biotechnology
2024
February 2024 Amendment to Retention and Separation Agreement for Nicole R. Hadas
Retention Agreements
Akebia Therapeutics, Inc.
Biotechnology
2024
February 2024 Amendment to Retention and Separation Agreement for Michel Dahan
Retention Agreements
Akebia Therapeutics, Inc.
Biotechnology
2024
Fourth Amendment to Loan Agreement dated as of October 31, 2023, by and among the Company, BioPharma Credit PLC, BPCR Limted Partnership, and BioPharma Credit Investments V...
Loan Agreements
Akebia Therapeutics, Inc.
Biotechnology
NY
2024
Agreement for the Provision of a Loan Facility dated January 29, 2024 between the Company and Kreos Capital VII (UK) Limited
Loan Agreements
Akebia Therapeutics, Inc.
Biotechnology
NY
2024
Warrant Agreement dated January 29, 2024 by and between the Company and Kreos Capital VII Aggregator SCSp
Warrant Agreements
Akebia Therapeutics, Inc.
Biotechnology
NY
2024
October 2023 Amendment to Retention and Separation Agreement for Nicole R. Hadas
Retention Agreements
Akebia Therapeutics, Inc.
Biotechnology
2023
License Agreement, dated May 24, 2023, by and between the Company and MEDICE Arzneimittel Ptter GmbH & Co. KG
License Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2023
Third Amendment to Loan Agreement, dated as of June 30, 2023, by and among the Company, Biopharma Credit plc, B
Loan Agreements
Akebia Therapeutics, Inc.
Biotechnology
NY
2023
Packaging Validation Transfer Agreement, dated April 20, 2023, by and between the Company and Otsuka Pharmaceutical Co. Ltd
Akebia Therapeutics, Inc.
Biotechnology
NY
2023
Form of May 2023 Amendment to Retention and Separation Agreement for Michel Dahan and Nicole R. Hadas
Retention Agreements
Akebia Therapeutics, Inc.
Biotechnology
2023
July 2023 Amendment to Retention and Separation Agreement for Michel Dahan
Retention Agreements
Akebia Therapeutics, Inc.
Biotechnology
2023
July 2023 Amendment to Retention and Separation Agreement for Nicole R. Hadas
Retention Agreements
Akebia Therapeutics, Inc.
Biotechnology
2023
Separation Agreement with David Spellman, dated June 9, 2023 and Amendment to Separation Agreement dated July 6, 2023
Separation Agreements
Akebia Therapeutics, Inc.
Biotechnology
2023
Second Amended and Restated Non-Employee Director Compensation Program, effective June 6, 2023
Compensation Agreements
Akebia Therapeutics, Inc.
Biotechnology
2023
Form of Non-Employee Director Stock Option Agreement under 2023 Stock Incentive Plan
Bonus & Incentive Agreements
Akebia Therapeutics, Inc.
Biotechnology
2023
Form of Officer Stock Option Agreement under 2023 Stock Incentive Plan
Bonus & Incentive Agreements
Akebia Therapeutics, Inc.
Biotechnology
2023
Form of Non-Employee Director Restricted Stock Unit Agreement under 2023 Stock Incentive Plan
Bonus & Incentive Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2023
Form of Officer Restricted Stock Unit Agreement under 2023 Stock Incentive Plan
Bonus & Incentive Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2023
Form of Officer Inducement Award Stock Option Agreement under 2023 Stock Incentive Plan
Bonus & Incentive Agreements
Akebia Therapeutics, Inc.
Biotechnology
2023
Amended and Restated
Akebia Therapeutics, Inc.
Biotechnology
2023
Amendment No. 5
Akebia Therapeutics, Inc.
Biotechnology
2023
Form of Stock Appreciation Rights Award Agreement for officers
Stock Agreements
Akebia Therapeutics, Inc.
Biotechnology
2023
Amendment No. 1 to Collaboration Agreement, dated December 2, 2022, by and between Akebia Therapeutics, Inc. and Mitsubishi Tanabe Pharma Corporation
Collaboration Agreements
Akebia Therapeutics, Inc.
Biotechnology
2023
Termination and Settlement Agreement, dated December 22, 2022, by and between Keryx Biopharmaceuticals, Inc. and BioVectra Inc
Termination Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2023
License Agreement, dated December 22, 2022, by and among Akebia Therapeutics, Inc., Keryx Biopharmaceuticals, Inc. and Averoa SAS
License Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2023
Form of Amendment to Retention and Separation Agreement for Michel Dahan and Nicole R. Hadas
Retention Agreements
Akebia Therapeutics, Inc.
Biotechnology
2022
Retention Agreement with David Spellman, dated June 22, 2022
Retention Agreements
Akebia Therapeutics, Inc.
Biotechnology
2022
Form of Officer Restricted Stock Unit Award Agreement
Stock Agreements
Akebia Therapeutics, Inc.
Biotechnology
2022
Form of Officer Non-Statutory Stock Option Agreement under 2014 Incentive Plan
Bonus & Incentive Agreements
Akebia Therapeutics, Inc.
Biotechnology
2022
Termination and Settlement Agreement, dated
Termination Agreements
Akebia Therapeutics, Inc.
Biotechnology
NY
2022
Second Amendment and Waiver, dated July 15, 2022, by and among the Company, Biopharma Credit plc, BCPR Limited Partnership and Biopharma Credit Investments V (Master) LP
Credit Agreements
Akebia Therapeutics, Inc.
Biotechnology
NY
2022
Form of Officer Retention Letter Agreement
Retention Agreements
Akebia Therapeutics, Inc.
Biotechnology
2022
Form of Retention and Separation Agreement for Michel Dahan and Nicole R. Hadas
Retention Agreements
Akebia Therapeutics, Inc.
Biotechnology
2022
Separation Agreement with Dell Faulkingham, dated May 5, 2022
Separation Agreements
Akebia Therapeutics, Inc.
Biotechnology
2022
Open Market Sale AgreementSM, dated April 7, 2022, by and between Akebia Therapeutics, Inc. and Jefferies LLC
Akebia Therapeutics, Inc.
Biotechnology
NY
2022
Investment Agreement between Akebia Therapeutics, Inc. and Vifor (International) Ltd., dated February 18, 2022
Investment Agreements
Akebia Therapeutics, Inc.
Biotechnology
MA
2022
First Amendment to One Marina Park Drive Office Lease, dated February 24, 2022, by and between Keryx Biopharmaceuticals, Inc. and CLPF One Marina Park Drive LLC...
Lease Agreements
Akebia Therapeutics, Inc.
Biotechnology
MA
2022
Assignment and Assumption Agreement, dated February 24, 2022, by and between Keryx Biopharmaceuticals, Inc. and Akebia Therapeutics, Inc
Assignment Agreements
Akebia Therapeutics, Inc.
Biotechnology
MA
2022
Amended and Restated Cash Incentive Plan, effective January 19, 2022
Bonus & Incentive Agreements
Akebia Therapeutics, Inc.
Biotechnology
2022
Collaboration Agreement between Akebia Therapeutics, Inc. and Mitsubishi Tanabe Pharma Corporation, dated December 11, 2015
Collaboration Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2022
Second Amended and Restated License Agreement, dated
License Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2022
Master Manufacturing Services Agreement by and between Keryx Biopharmaceuticals, Inc. and Patheon Manufacturing Services LLC and certain of its affiliates, dated September 27,...
Services Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2022
Amendment No. 4 to Master Manufacturing Services and Supply Agreement, dated as of December 17, 2021, by and between Siegfried Evionnaz SA and Keryx Biopharmaceuticals, Inc
Supply Agreements
Akebia Therapeutics, Inc.
Biotechnology
2022
First Amendment and
Akebia Therapeutics, Inc.
Biotechnology
NY
2022
Form of Officer Performance-Based Stock Option Award, under the Company's 2014 Incentive Plan, as amended
Bonus & Incentive Agreements
Akebia Therapeutics, Inc.
Biotechnology
2021
Form of Officer Performance-Based Restricted Stock Unit Award, under the Company's 2014 Incentive Plan, as amended
Bonus & Incentive Agreements
Akebia Therapeutics, Inc.
Biotechnology
2021
Form of Officer Cash Bonus Letter Agreement
Bonus & Incentive Agreements
Akebia Therapeutics, Inc.
Biotechnology
2021
Amendment #1 to the Supply Agreement, dated as of April 15, 2021, by and between Akebia Therapeutics, Inc, and STA Pharmaceutical Hong Kong Limited
Supply Agreements
Akebia Therapeutics, Inc.
Biotechnology
2021
Supply Agreement, dated February 10, 2021, by and between the Company and STA Pharmaceutical Hong Kong Limited
Supply Agreements
Akebia Therapeutics, Inc.
Biotechnology
2021
Royalty Interest Acquisition Agreement, dated February 25, 2021, by and between the Company and HealthCare Royalty Partners IV, L.P
Akebia Therapeutics, Inc.
Biotechnology
DE
2021
Description of Registrants Securities
Akebia Therapeutics, Inc.
Biotechnology
2021
Sixth Amendment to Office Lease Agreement Between CLPF-Cambridge Science Center, LLC and Akebia Therapeutics, Inc. dated November 30, 2020
Lease Agreements
Akebia Therapeutics, Inc.
Biotechnology
MA
2021
Non-Employee Director Compensation Program, effective January
Compensation Agreements
Akebia Therapeutics, Inc.
Biotechnology
2021
Amendment No. 1 to Master Manufacturing Services and Supply Agreement, dated as of December 21, 2020, by and between Siegfried Evionnaz SA and Keryx Biopharmaceuticals, Inc
Supply Agreements
Akebia Therapeutics, Inc.
Biotechnology
2021
Amendment No. 2 to Master Manufacturing Services and Supply Agreement, dated as of January 29, 2021, by and between Siegfried Evionnaz SA and Keryx Biopharmaceuticals, Inc
Supply Agreements
Akebia Therapeutics, Inc.
Biotechnology
2021
Amendment No. 3 to Master Manufacturing Services and Supply Agreement, dated as of February 11, 2021, by and between Siegfried Evionnaz SA and Keryx Biopharmaceuticals, Inc
Supply Agreements
Akebia Therapeutics, Inc.
Biotechnology
2021
Consulting Agreement
Consulting Agreements
Akebia Therapeutics, Inc.
Biotechnology
MA
2020
Amended and Restated Product Manufacture and Supply and Facility Construction Agreement between BioVectra, Inc. and Keryx Biopharmaceuticals, Inc., dated September 4, 2020
Supply Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2020
Offer Letter to David Spellman, dated as of June 13
Akebia Therapeutics, Inc.
Biotechnology
2020
Supply Agreement, dated as of April 2, 2020, by and between Akebia Therapeutics, Inc. and STA Pharmaceutical Hong Kong Limited
Supply Agreements
Akebia Therapeutics, Inc.
Biotechnology
2020
Underwriting Agreement, dated May 11, 2020, by and among Akebia Therapeutics, Inc. and J.P. Morgan Securities LLC and Piper Sandler & Co., as representatives of the several...
Underwriting Agreements
Akebia Therapeutics, Inc.
Biotechnology
NY
2020
Supply Agreement, dated as of March 11, 2020, by and between Akebia Therapeutics, Inc. and Patheon, Inc
Supply Agreements
Akebia Therapeutics, Inc.
Biotechnology
2020
Description of Registrants Securities
Akebia Therapeutics, Inc.
Biotechnology
2020
Guaranty and Security Agreement, dated November 25, 2019, by and between the Company, Keryx Biopharmaceuticals, Inc. and Biopharma Credit plc
Credit Agreements
Akebia Therapeutics, Inc.
Biotechnology
NY
2020
Loan Agreement, dated November 11, 2019, by and among the Company, Keryx Biopharmaceuticals, Inc., Biopharma Credit plc and Biopharma Credit Investments V (Master) LP
Loan Agreements
Akebia Therapeutics, Inc.
Biotechnology
NY
2020
Sublease, dated as of September 9, 2019, by and between Keryx Biopharmaceuticals, Inc. and Foundation Medicine, Inc
Lease Agreements
Akebia Therapeutics, Inc.
Biotechnology
2019
Waiver and First Amendment to Loan Security and Security Agreement, dated as of July 31, 2019, by and between Keryx Biopharmaceuticals, Inc. and Silicon Valley Bank
Loan Agreements
Akebia Therapeutics, Inc.
Biotechnology
MA
2019
Security Agreement, dated as of August 7, 2019, by and between Akebia Therapeutics, Inc. and Silicon Valley Bank
Security Agreements
Akebia Therapeutics, Inc.
Biotechnology
MA
2019
Unconditional Guaranty, dates as August 7, 2019, by and between Akebia Therapeutics, Inc. and Silicon Valley Bank
Guaranty Agreements
Akebia Therapeutics, Inc.
Biotechnology
MA
2019
Controlled Equity OfferingSM Amended and Restated Sales Agreement, dated as of November 12, 2019, by and between the Company and Cantor Fitzgerald & Co
Sales Agreements
Akebia Therapeutics, Inc.
Biotechnology
NY
2019
Second Amended and Restated License Agreement, dated as of April 17, 2019, by and between Akebia Therapeutics, Inc. and Panion & BF Biotech, Inc
License Agreements
Akebia Therapeutics, Inc.
Biotechnology
NY
2019
Supply Agreement, dated as of April 9, 2019, by and between Akebia Therapeutics, Inc. and Esteve Qumica, S.A
Supply Agreements
Akebia Therapeutics, Inc.
Biotechnology
MA
2019
Master Consulting Services Agreement, dated as of June 10, 2019, by and between Akebia Therapeutics, Inc. and Scott A. Canute
Consulting Agreements
Akebia Therapeutics, Inc.
Biotechnology
MA
2019
Amended and Restated License Agreement, dated as of April 8, 2019, by and between Akebia Therapeutics, Inc. and Vifor (International) Ltd
License Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2019
Form of Officer Restricted Stock Unit Award Agreement under 2014 Incentive Plan
Bonus & Incentive Agreements
Akebia Therapeutics, Inc.
Biotechnology
2019
Amended and Restated Non-Employee Director Compensation Program, effective January 30, 2019
Compensation Agreements
Akebia Therapeutics, Inc.
Biotechnology
2019
Letter Agreement by and between Panion & BF Biotech, Inc., the Company and Keryx Biopharmaceuticals, Inc. dated October 24, 2018
Akebia Therapeutics, Inc.
Biotechnology
NY
2019
Form of Employee Agreement (Confidentiality, Non-Competition, Non-Solicitation and Development Agreement) applicable to officers
Non-Competition Agreements
Akebia Therapeutics, Inc.
Biotechnology
MA
2019
Keryx Biopharmaceuticals, Inc. Director Non-Statutory Stock Option Award Terms and Conditions under the Third Amended and Restated Directors Equity Compensation Plan
Stock Agreements
Akebia Therapeutics, Inc.
Biotechnology
2019
Exclusive Distribution Agreement between Keryx Biopharmaceuticals, Inc. and Cardinal Health 105, Inc., dated October 16, 2014 and Amendment to Exclusive Distribution Agreement...
Distribution Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2019
Manufacture and Supply Agreement between Keryx Biopharmaceuticals, Inc. and BioVectra Inc., dated May 26, 2017 and Amendment to Manufacture and Supply Agreement between Keryx...
Supply Agreements
Akebia Therapeutics, Inc.
Biotechnology
2019
Registration Rights Agreement, dated December 12, 2018, by and between Akebia Therapeutics, Inc. and Baupost Group Securities, L.L.C
Registration Rights Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2018
First Amendment to Agreement and Plan of Merger dated October 1, 2018
Merger Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2018
Fifth Amendment to Office Lease Agreement Between CLPF-Cambridge Science Center, LLC and Akebia Therapeutics, Inc. dated April 9, 2018
Lease Agreements
Akebia Therapeutics, Inc.
Biotechnology
MA
2018
Agreement and Plan of Merger, dated as of June 28, 2018, by and among Akebia Therapeutics, Inc., Alpha Therapeutics Merger Sub, Inc., and Keryx Biopharmaceuticals, Inc
Merger Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2018
Notes Conversion Agreement, dated as of June 28, 2018, by and among Akebia Therapeutics, Inc., Keryx Biopharmaceuticals, Inc. and Baupost Group Securities, L.L.C
Note Agreements
Akebia Therapeutics, Inc.
Biotechnology
NY
2018
Underwriting Agreement, dated March 22, 2018, between Akebia Therapeutics, Inc. and Morgan Stanley & Co. LLC, as underwriter
Underwriting Agreements
Akebia Therapeutics, Inc.
Biotechnology
NY
2018
Amendment No. 1 to Fourth Amended and Restated Investors Rights Agreement, dated June 28, 2017
Investor Rights Agreements
Akebia Therapeutics, Inc.
Biotechnology
2018
Form of Director and Officer Indemnification Agreement
Indemnification Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2018
Fourth Amendment to Office Lease Agreement Between CLPF-Cambridge Science Center, LLC and Akebia Therapeutics, Inc., dated May 1, 2017
Lease Agreements
Akebia Therapeutics, Inc.
Biotechnology
MA
2018
Non-Employee Director Compensation Program
Compensation Agreements
Akebia Therapeutics, Inc.
Biotechnology
2018
Form of Restricted Stock Unit Award Agreement under 2014 Incentive Plan
Bonus & Incentive Agreements
Akebia Therapeutics, Inc.
Biotechnology
2018
Offer Letter to Rita Jain, dated April 28, 2017
Akebia Therapeutics, Inc.
Biotechnology
2018
Letter Agreement between Akebia Therapeutics, Inc. and Mitsubishi Tanabe Pharma Corporation, dated September 26, 2017
Akebia Therapeutics, Inc.
Biotechnology
2017
Investment Agreement between Akebia Therapeutics, Inc. and Vifor (International) Ltd., dated May 12, 2017
Investment Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2017
4,000,000 Shares AKEBIA THERAPEUTICS, INC. COMMON STOCK, PAR VALUE $0.00001 PER SHARE UNDERWRITING AGREEMENT
Underwriting Agreements
Akebia Therapeutics, Inc.
Biotechnology
NY
2017
CONFIDENTIAL
Akebia Therapeutics, Inc.
Biotechnology
NY
2017
CONFIDENTIAL RESEARCH AND LICENSE AGREEMENT between AKEBIA THERAPEUTICS, INC. and Janssen Pharmaceutica NV Dated as of February 9, 2017
License Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2017
THIRD AMENDMENT TO LEASE
Lease Agreements
Akebia Therapeutics, Inc.
Biotechnology
MA
2016
SECOND AMENDMENT TO LEASE
Lease Agreements
Akebia Therapeutics, Inc.
Biotechnology
2016
CONFIDENTIAL COLLABORATION AGREEMENT BY AND BETWEEN AKEBIA THERAPEUTICS, INC. AND MITSUBISHI TANABE PHARMA CORPORATION
Collaboration Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2016
7,250,000 Shares AKEBIA THERAPEUTICS, INC. COMMON STOCK, PAR VALUE $0.00001 PER SHARE UNDERWRITING AGREEMENT
Underwriting Agreements
Akebia Therapeutics, Inc.
Biotechnology
NY
2016
MASTER SERVICES AGREEMENT
Services Agreements
Akebia Therapeutics, Inc.
Biotechnology
MA
2015
AKEBIA THERAPEUTICS, INC. Shares of Common Stock (par value$0.00001 per share) Controlled Equity OfferingSM Sales Agreement
Stock Agreements
Akebia Therapeutics, Inc.
Biotechnology
NY
2015
7,272,727 Shares AKEBIA THERAPEUTICS, INC. COMMON STOCK, PAR VALUE $0.00001 PER SHARE UNDERWRITING AGREEMENT
Underwriting Agreements
Akebia Therapeutics, Inc.
Biotechnology
NY
2015
FOURTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT TABLE OF CONTENTS
Investor Rights Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2015
FIRST AMENDMENT TO LEASE
Lease Agreements
Akebia Therapeutics, Inc.
Biotechnology
2015
Restricted Stock Unit Award granted under the AKEBIA THERAPEUTICS, INC. 2014 Incentive Plan Restricted Stock Unit Award Agreement
Bonus & Incentive Agreements
Akebia Therapeutics, Inc.
Biotechnology
2015
Shares AKEBIA THERAPEUTICS, INC. COMMON STOCK, PAR VALUE $0.00001 PER SHARE UNDERWRITING AGREEMENT
Underwriting Agreements
Akebia Therapeutics, Inc.
Biotechnology
MA
2014
FOURTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT TABLE OF CONTENTS
Investor Rights Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2014
AKEBIA THERAPEUTICS, INC. INDEMNIFICATION AGREEMENT
Indemnification Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2014
STOCK OPTION AWARD granted under the AKEBIA THERAPEUTICS, INC. 2014 INCENTIVE PLAN NON-STATUTORY STOCK OPTION AGREEMENT
Bonus & Incentive Agreements
Akebia Therapeutics, Inc.
Biotechnology
2014
OFFICER STOCK OPTION AWARD granted under the AKEBIA THERAPEUTICS, INC. 2014 INCENTIVE PLAN NON-STATUTORY STOCK OPTION AGREEMENT
Bonus & Incentive Agreements
Akebia Therapeutics, Inc.
Biotechnology
2014
NON-EMPLOYEE DIRECTOR STOCKOPTION AWARD granted under the AKEBIA THERAPEUTICS, INC. 2014 INCENTIVE PLAN NON-STATUTORY STOCK OPTION AGREEMENT
Bonus & Incentive Agreements
Akebia Therapeutics, Inc.
Biotechnology
2014
AKEBIA THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM
Compensation Agreements
Akebia Therapeutics, Inc.
Biotechnology
2014
EXECUTIVE SEVERANCE AGREEMENT
Severance Agreements
Akebia Therapeutics, Inc.
Biotechnology
MA
2014
EXECUTIVE SEVERANCE AGREEMENT
Severance Agreements
Akebia Therapeutics, Inc.
Biotechnology
MA
2014
AKEBIA THERAPEUTICS, INC. 2014 INCENTIVE PLAN
Bonus & Incentive Agreements
Akebia Therapeutics, Inc.
Biotechnology
MA
2014
AKEBIA THERAPEUTICS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN
Stock Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2014
AKEBIA THERAPEUTICS, INC. CASH INCENTIVE PLAN
Bonus & Incentive Agreements
Akebia Therapeutics, Inc.
Biotechnology
2014
THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES...
Exchange Agreements
Akebia Therapeutics, Inc.
Biotechnology
NY
2014
THIRDAMENDED AND RESTATED VOTING AGREEMENT TABLE OF CONTENTS
Voting Agreements
Akebia Therapeutics, Inc.
Biotechnology
2014
AMENDMENT NO. 1 TO THETHIRD AMENDED AND RESTATED VOTING AGREEMENT
Voting Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2014
THIRDAMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT TABLE OF CONTENTS
Investor Rights Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2014
AMENDMENT NO. 1 TO THETHIRD AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT
Investor Rights Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2014
SECOND AMENDED AND RESTATED RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT
Akebia Therapeutics, Inc.
Biotechnology
DE
2014
AMENDMENT NUMBER ONE TO SECOND AMENDED AND RESTATED RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT
Akebia Therapeutics, Inc.
Biotechnology
DE
2014
AMENDMENT NUMBER TWO TO THE SECOND AMENDED AND RESTATED RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT
Akebia Therapeutics, Inc.
Biotechnology
DE
2014
CAMBRIDGE SCIENCE CENTER AND 245 FIRST STREET CAMBRIDGE, MASSACHUSETTS OFFICE LEASE AGREEMENT BETWEEN MA-RIVERVIEW/245 FIRST STREET, L.L.C. a Delaware limited liability company...
Lease Agreements
Akebia Therapeutics, Inc.
Biotechnology
2014
AMENDED AND RESTATED ADMINISTRATIVE SERVICES AGREEMENT
Services Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2014
ADMINISTRATIVE SERVICES AGREEMENT
Services Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2014
AKEBIA THERAPEUTICS, INC. AMENDED AND RESTATED 2008 EQUITY INCENTIVE PLAN ARTICLE I ESTABLISHMENT AND TERM
Bonus & Incentive Agreements
Akebia Therapeutics, Inc.
Biotechnology
2014
AKEBIA THERAPEUTICS, INC. AMENDMENT NO. 1 TO AMENDED AND RESTATED 2008 EQUITY INCENTIVE PLAN Effective as of May 10, 2013
Bonus & Incentive Agreements
Akebia Therapeutics, Inc.
Biotechnology
2014
EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
Akebia Therapeutics, Inc.
Biotechnology
OH
2014
EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
Akebia Therapeutics, Inc.
Biotechnology
MA
2014
EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
Akebia Therapeutics, Inc.
Biotechnology
OH
2014
SEPARATION AGREEMENT
Separation Agreements
Akebia Therapeutics, Inc.
Biotechnology
2014
EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
Akebia Therapeutics, Inc.
Biotechnology
OH
2014
Amendment No. 1 to EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
Akebia Therapeutics, Inc.
Biotechnology
2014
CONSULTINGAGREEMENT
Akebia Therapeutics, Inc.
Biotechnology
OH
2014
SEPARATIONAGREEMENT
Akebia Therapeutics, Inc.
Biotechnology
2014
Akebia Therapeutics, Inc. AMENDED AND RESTATED PARTIAL RECOURSE PROMISSORY NOTE
Note Agreements
Akebia Therapeutics, Inc.
Biotechnology
2014
Akebia Therapeutics, Inc. AMENDED AND RESTATED PARTIAL RECOURSE PROMISSORY NOTE
Note Agreements
Akebia Therapeutics, Inc.
Biotechnology
2014
Akebia Therapeutics, Inc. AMENDED AND RESTATED PARTIAL RECOURSE PROMISSORY NOTE
Note Agreements
Akebia Therapeutics, Inc.
Biotechnology
2014
Akebia Therapeutics, Inc. AMENDED AND RESTATED PARTIAL RECOURSE PROMISSORY NOTE
Note Agreements
Akebia Therapeutics, Inc.
Biotechnology
2014
FORGIVENESS AND RELEASE AGREEMENT
Release Agreements
Akebia Therapeutics, Inc.
Biotechnology
2014